Ferroptosis and Cuproptosis: Mechanism and Crosstalk in Cancer, Neurodegeneration, and Metabolic Syndrome
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 2265
Special Issue Editor
Interests: neurodegenerative disorders; colorectal cancer; essential metals; Alzheimer’s disease; psychiatric disorders; copper; iron; zinc
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This special issue explores the emerging concepts of ferroptosis and cuproptosis, two distinct forms of regulated cell death, and their roles in cancer, neurodegeneration, and metabolic syndrome. The scope of the special issue spans the mechanisms underlying ferroptosis and cuproptosis, their interconnection, and their crosstalk in various diseases. Topics covered include but are not limited to, Alzheimer's disease, psychiatric disorders, and colorectal cancer, highlighting how these forms of cell death contribute to disease progression and potential therapeutic strategies. By examining the interplay of iron and copper metabolism in disease pathogenesis, this special issue provides a comprehensive view of how ferroptosis and cuproptosis impact cellular function and contribute to various pathological conditions, opening new avenues for targeted treatment.
Suitable topics include, but are not limited to: Alzheimer's disease, psychiatric disorders, and colorectal cancer.
You may choose our Joint Special Issue in International Journal of Molecular Sciences.
Dr. Rosanna Squitti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ferroptosis
- cuproptosis
- Alzheimer's disease
- colorectal cancer
- neurodegeneration
- metabolic syndrome
- regulated cell death
- iron metabolism
- copper metabolism
- psychiatric disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
